OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.
van Praag RM, Prins JM, Roos MT, Schellekens PT, Ten Berge IJ, Yong SL, Schuitemaker H, Eerenberg AJ, Jurriaans S, de Wolf F, Fox CH, Goudsmit J, Miedema F, Lange JM.
van Praag RM, et al. Among authors: schellekens pt.
J Clin Immunol. 2001 May;21(3):218-26. doi: 10.1023/a:1011091300321.
J Clin Immunol. 2001.
PMID: 11403229